Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.72% | -24.51% | 1.44% | 9.54% | 73.73% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,179.03% | -98.19% | -88.66% | -199.28% | -99.47% |
| Change in Net Operating Assets | -201.05% | -53.03% | -46.96% | 97.19% | 50.01% |
| Cash from Operations | -40.48% | -51.47% | 14.90% | 31.07% | -83.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -2,451.02% | -4.89% | -5.22% | -45.43% |
| Issuance of Common Stock | -- | -100.00% | -100.00% | 43.33% | 1,900.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.38% | 229.67% | -116.20% | 182.47% | -44.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.80% | 425.23% | -100.07% | 281.10% | 0.17% |